Deletion 9q as the sole karyotypic abnormality in myelocytic disorders: A new case of myelodysplastic syndrome and its prognostic implications in acute myelocytic leukemia [2]

Cancer Genetics and Cytogenetics

Volumn 145, Issue 2, 2003, Pages 184-186

  Wan, T S K ^a   Ma, E S K ^a   Lam, C C K ^a   Chan, L C ^a   Lee, K K ^b   Au, W Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; AGED; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME 9Q; CHROMOSOME ISOLATION; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FLOW CYTOMETRY; GENE DELETION; HUMAN; HUMAN TISSUE; KARYOTYPING; LABORATORY TEST; LETTER; MALE; MYELODYSPLASTIC SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; WORLD HEALTH ORGANIZATION;

EID: 0041662166     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00060-8     Document Type: Letter

References (12)

1. Michalova K., Musilova J., Zemanova Z. Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Czechoslovak MDS Cooperative Group. Ann Genet. 34:1991;212-218.
2. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated August 2002. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman .
3. Hoyle C., Sherrington P.D., Hayhoe F.G.J. Cytological features of 9q- deletions in AML. Br J Haematol. 66:1987;277-278.
4. Akashi K., Shibuya T., Harada M., Oogami A., Teshima T., Takamatsu Y., Kikuchi M., Niho Y. Interstitial 9q in T-lymphoid/myeloid biphenotypic leukemia. Br J Haematol. 80:1991;172-177.
5. Kwong Y.L., Chan T.K., Chan L.C. Interstitial deletion of long arm of chromosome 9 as the sole anomaly in acute myeloid leukemia is associated with dyserythropoiesis. Leukemia. 6:1992;64-65.
6. Chim C.S., Au W.Y., Shek T.W.H., Ho J., Choy C., Ma S.K., Tung H.M., Liang R., Kwong Y.L. Primary CD56 positive lymphomas of the gastrointestinal tract. Cancer. 91:2001;525-533.
7. Wan T.S.K., Ma S.K., Ho M.Y., Chan L.C., Yip S.F., Wong L.G., Yeung Y.M. Cytogenetic biclonality in polycythemia vera: unusual and unrelated clones. Cancer Genet Cytogenet. 131:2001;86-89.
8. Kwong Y.L., Ha S.Y., Liang R.H.S., Wan T.S.K., Chan L.C. Interstitial deletion of 9q in a case of acute myeloid leukemia (FAB M6). Cancer Genet Cytogenet. 66:1993;79-80.
9. Kwong Y.L., Chan L.C. Concomitant presence of trisomy 21 and del(9q) in acute myeloid leukemia. Cancer Genet Cytogenet. 64:1992;93-94.
10. Horrigan S.K., Arbieva Z.H., Xie H.Y., Kravarusic J., Fulton N.C., Naik H., Le T.T., Westbrook C.A. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. Blood. 95:2000;2372-2377.
11. Liang H., Fairman J., Claxton D.F., Nowell P.C., Green E.D., Nagarajan L. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc Natl Acad Sci USA. 95:1998;3781-3785.
12. Sweetser D.A., Daly S.B., Haaland-Pullus C., Side L.E., Blomberg A.A., Bernstein I.D., Wainscoat J.S., Boultwood J., Peniket A.J. Identification of candidate tumor suppressor genes in the commonly deleted region of del(9q) AML. [abstract 1194] Blood. 100:2002;308a.